Harrow, Inc. (NasdaqGM: HROW)
Health Care · Pharmaceuticals · US
$29.33
-0.10% today · -27.6% 1Y
Harrow, Inc. (NasdaqGM: HROW) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.10B and employs 373 people.
Over the last twelve months the share price has lost 27.6%, trading between 27.00 and 54.85.
Tweenvest scores Harrow, Inc. across four factors: quality 46/100, value 63/100, growth 100/100. Its strongest factor is growth.
HROW price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.10B
- Revenue (TTM)
- $275.59M
- P/E
- —
- EPS
- -1.00
- Dividend yield
- —
- Beta (5Y)
- 0.18
- 52-week high
- $54.85
- 52-week low
- $27.00
- Avg volume (3M)
- —
- Shares outstanding
- 37.49M
- Employees
- 373
- Next earnings
- —
About Harrow, Inc.
Harrow Health, Inc. operates as a healthcare enterprise with a specialized focus on ophthalmic solutions. The company's portfolio includes ImprimisRx, a business dedicated to ophthalmology outsourcing and pharmaceutical compounding, as well as DEXYCU, a product utilized for managing post-operative inflammation. Beyond its direct offerings, Harrow Health maintains equity investments in several pharmaceutical ventures. These encompass Surface Ophthalmics, Inc., a clinical-stage firm actively developing and commercializing therapeutic agents for ocular surface diseases; Melt Pharmaceuticals, Inc., another clinical-stage entity concentrating on proprietary non-intravenous sedation and anesthesia treatments for various medical procedures conducted in hospital, outpatient, and office environments; and Eton Pharmaceuticals, Inc., a commercial-stage company involved in the creation and market launch of drug products. Moreover, Harrow Health holds royalty interests in four investigational drug candidates currently being advanced by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company, initially incorporated in 2006 and based in San Diego, California, underwent a name change from Imprimis Pharmaceuticals, Inc. to Harrow Health, Inc. in December 2018.
- ISIN
- US4158581094
- Founded
- 1998
- Listed since
- Sep 28, 2007
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Jiuzhitang Co., Ltd.SZSE: 000989 | $1.13B | CN¥8.91 | +1.83% |
| Towa Pharmaceutical Co., Ltd.TSE: 4553 | $1.13B | ¥3,620.00 | +3.58% |
| Shanghai Yizhong Pharmaceutical Co., Ltd.SHSE: 688091 | $1.13B | CN¥36.80 | -6.60% |
| Sichuan Huiyu Pharmaceutical Co., Ltd.SHSE: 688553 | $1.10B | CN¥11.85 | -7.78% |
| Renhe Pharmacy Co.,LtdSZSE: 000650 | $1.09B | CN¥5.29 | +0.95% |
| Guilin Sanjin Pharmaceutical Co., Ltd.SZSE: 002275 | $1.08B | CN¥12.35 | +1.06% |
| Oscotec Inc.KOSDAQ: A039200 | $1.07B | ₩37,700.00 | +3.01% |
| Guangxi Wuzhou Zhongheng Group Co., LtdSHSE: 600252 | $1.07B | CN¥2.25 | +2.27% |
Figures last refreshed Oct 11, 2026.